List of Threshold Pharmaceuticals patents

List of Threshold Pharmaceuticals patents

List of Articulate Labs patents

List of Vicarious patents

List of Tamagawa Seiki patents

List of footwear products

CEOs of assisted living companies

Patents where

Current Assignee

Name

is

Threshold Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9254299 Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer	Patent 9254299 was granted and assigned to Threshold Pharmaceuticals on February, 2016 by the United States Patent and Trademark Office.	Threshold Pharmaceuticals	Threshold Pharmaceuticals		United States Patent and Trademark Office	9254299	February 9, 2016
	‌ US Patent 9226932 Phosphoramidate alkylator prodrugs	Patent 9226932 was granted and assigned to Threshold Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.	Threshold Pharmaceuticals	Threshold Pharmaceuticals		United States Patent and Trademark Office	9226932	January 5, 2016
	‌ US Patent 9205098 Anti-cancer therapies	Patent 9205098 was granted and assigned to Threshold Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.	Threshold Pharmaceuticals	Threshold Pharmaceuticals		United States Patent and Trademark Office	9205098	December 8, 2015
	‌ US Patent 8664204 Phosphoramidate alkylator prodrugs	Patent 8664204 was granted and assigned to Threshold Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.	Threshold Pharmaceuticals	Threshold Pharmaceuticals		United States Patent and Trademark Office	8664204	March 4, 2014
	‌ US Patent 8946275 Treatment of cancer using hypoxia activated prodrugs	Patent 8946275 was granted and assigned to Threshold Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8946275	February 3, 2015
	‌ US Patent 8765690 Treatment of cancer with glufosfamide in patients not receiving insulin therapy	Patent 8765690 was granted and assigned to Threshold Pharmaceuticals on July, 2014 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8765690	July 1, 2014
	‌ US Patent 8299088 Compositions and methods for treating cancer	Patent 8299088 was granted and assigned to Threshold Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8299088	October 30, 2012
	‌ US Patent 8507464 Phosphoramidate alkylator prodrugs	Patent 8507464 was granted and assigned to Threshold Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8507464	August 13, 2013
	‌ US Patent 8575188 Camptothecin derivatives			Threshold Pharmaceuticals		United States Patent and Trademark Office	8575188	November 5, 2013
	‌ US Patent 8552048 Phosphoramidate alkylator prodrugs for the treatment of cancer	Patent 8552048 was granted and assigned to Threshold Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8552048	October 8, 2013
	‌ US Patent 8318683 Anti-cancer therapies	Patent 8318683 was granted and assigned to Threshold Pharmaceuticals on November, 2012 by the United States Patent and Trademark Office.		Threshold Pharmaceuticals		United States Patent and Trademark Office	8318683	November 27, 2012
	‌ US Patent 8309554 Hypoxia activated drugs of nitrogen mustard alkylators			Threshold Pharmaceuticals		United States Patent and Trademark Office	8309554	November 13, 2012

12 results

0 selected

12 results

0 selected